152 related articles for article (PubMed ID: 26990915)
1. Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.
Yang Y; Gao J; Li HL; Zheng W; Yang G; Zhang W; Ma X; Tan YT; Rothman N; Gao YT; Chow WH; Shu XO; Xiang YB
Int J Cancer; 2016 Jul; 139(2):355-62. PubMed ID: 26990915
[TBL] [Abstract][Full Text] [Related]
2. Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk.
Yang Y; Gao J; Tan YT; Li HL; Wang J; Ma X; Zheng W; Shu XO; Xiang YB
J Gastroenterol Hepatol; 2018 May; 33(5):1131-1137. PubMed ID: 29065440
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
5. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
7. Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population.
Liu X; Baecker A; Wu M; Zhou JY; Yang J; Han RQ; Wang PH; Jin ZY; Liu AM; Gu X; Zhang XF; Wang XS; Su M; Hu X; Sun Z; Li G; Mu L; He N; Li L; Zhao JK; Zhang ZF
Int J Cancer; 2018 Apr; 142(8):1560-1567. PubMed ID: 29193051
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
[TBL] [Abstract][Full Text] [Related]
10. [Interaction among the relative risk factors of primary liver cancer in a case-control study].
Zhao N; Yu S; Sun WM
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):90-3. PubMed ID: 7923340
[TBL] [Abstract][Full Text] [Related]
11. Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.
Muñoz A; Chen JG; Egner PA; Marshall ML; Johnson JL; Schneider MF; Lu JH; Zhu YR; Wang JB; Chen TY; Kensler TW; Groopman JD
Carcinogenesis; 2011 Jun; 32(6):860-5. PubMed ID: 21474708
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.
Park YM; Lee SG
World J Gastroenterol; 2016 Nov; 22(44):9836-9843. PubMed ID: 27956808
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size.
Luo Z; Xie Y; Deng M; Zhou X; Ruan B
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):695-700. PubMed ID: 21617533
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
Yeh FS; Yu MC; Mo CC; Luo S; Tong MJ; Henderson BE
Cancer Res; 1989 May; 49(9):2506-9. PubMed ID: 2539905
[TBL] [Abstract][Full Text] [Related]
15. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
18. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
20. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
Welzel TM; Katki HA; Sakoda LC; Evans AA; London WT; Chen G; O'Broin S; Shen FM; Lin WY; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1279-82. PubMed ID: 17548697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]